Global Neurovascular Catheters Market

Neurovascular Catheters Market Size, Share, Growth Analysis, By Application(Embolic Stroke, Brain Aneurysms), By Type(Micro, Balloon) - Industry Forecast 2024-2031

Report ID: SQMIG35A2523 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 66 | Figures: 77

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Neurovascular Catheters Market size was valued at USD 3.03 Billion in 2022 and is poised to grow from USD 3.25 Billion in 2023 to USD 5.66 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

The major challenge in the neurovascular catheters market is the high cost of procedures. Neurovascular procedures are complex and require specialized equipment, skilled healthcare professionals, and significant hospital resources. The high cost of procedures can limit their accessibility to patients, particularly in developing countries, where healthcare infrastructure and resources are limited. 'Medtronic plc (Ireland)', 'Stryker Corporation (US)', 'Terumo Corporation (Japan)', 'Penumbra, Inc. (US)', 'MicroPort Scientific Corporation (China)', 'Johnson & Johnson (US)', 'Merit Medical Systems, Inc. (US)', 'Integer Holdings Corporation (US)', 'Teleflex Incorporated (US)', 'Penumbra, Inc. (US)', 'Rapid Medical Ltd. (Israel)', 'MicroVention, Inc. (US)', 'Acandis GmbH (Germany)', 'Balt Extrusion (France)', 'Covidien (US)', 'Boston Scientific Corporation (US)', 'Cook Medical LLC (US)', 'Phenox GmbH (Germany)', 'Stryker Neurovascular (US)', 'Balt USA LLC (US)', 'Metactive Medical, Inc. (US)', 'Amplitude Surgical SA (France)'

The rising prevalence of neurological disorders such as stroke, aneurysms, and arteriovenous malformations (AVMs) is driving demand for neurovascular catheters. These catheters are used to diagnose and treat these conditions, and as the prevalence of these disorders increases, so too does demand for neurovascular catheters.

The increasing incidence of neurological disorders, such as stroke, aneurysms, and arteriovenous malformations, is driving the demand for neurovascular catheters. According to the World Health Organization (WHO), stroke is the second leading cause of death globally, and the demand for effective treatment options for neurological disorders is increasing.

Due to the presence of significant manufacturers in the area, including Penumbra, Inc., Stryker Corporation, Merit Medical Systems, Inc., and Johnson & Johnson, North America had the lion's share of the market in 2022 (33.23%). For instance, J&J's Cerenovus would invest USD 54.19 million in an Irish research facility's development of stroke devices in February 2022. The Rist Selective Radial Access Catheter and the Rist 079 Radial Access Guide Catheter, a groundbreaking radial access catheter system, will also be available in July 2021 thanks to a Health Canada licence obtained by Medtronic Canada ULC, a division of Medtronic

Related Reports

Cosmetic Implants Market
Buy Now GET FREE SAMPLE
Self-injection Devices Market
Buy Now GET FREE SAMPLE
Thermal Underwear Market
Buy Now GET FREE SAMPLE
Transplant Diagnostics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Neurovascular Catheters Market

Product ID: SQMIG35A2523

$5,300
BUY NOW